French Media Stock News

In recent weeks, the European markets have shown resilience, with the pan-European STOXX Europe 600 Index reaching new highs driven by strong corporate earnings and a recovery in sentiment toward AI-related stocks. As investors navigate these evolving conditions, identifying potentially undervalued stocks can be a strategic approach to capitalize on market opportunities.

The investors in Worldline SA 's ( EPA:WLN ) will be rubbing their hands together with glee today, after the share...

Why Safran stock is in focus after new guidance and half year results Safran (ENXTPA:SAF) drew fresh attention after its board met on 27 July to review half year 2026 figures and the company raised full year revenue growth guidance despite a drop in net income. The company now expects 2026 revenue growth in the mid teens, with management indicating a target above €36b. This update followed half year 2026 sales of €17,245m and revenue of €17,458m. See our latest analysis for Safran. Safran’s...

Eurazeo stock barely flinched into these H1 2026 results, with the shares at €50.65 after a solid run over the past month. Yet the earnings story is less about the share price and more about the balance sheet. The group still sits on a rich price to sales multiple of 9.3x while reporting losses on a trailing twelve month basis. The real headline is the tension between a high valuation, ongoing losses and a 6.34% dividend yield that is poorly covered by earnings and free cash flow. Like the...

The market has spent the past three months marking Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée down, with the stock now about 12% lower even after closing at €138. Yet the latest half year numbers tell a more complicated story. Earnings over the last 12 months reached €105.3 million and the net profit margin sits at 23.1%. The stock trades on a P/E of 9.7x, which leaves you weighing a cheaper valuation against a bank that still carries 65% of its liabilities in higher risk...

Why Arkema’s Latest Half Year Earnings Matter For Investors Arkema (ENXTPA:AKE) reported half year 2026 results with sales of €4,609.6 million and net income of €92.9 million, both lower than a year earlier. Earnings per share also declined over the period. See our latest analysis for Arkema. Arkema’s latest half year earnings came alongside a 1 month share price return of 8.04% and a year to date share price return of 16.81%, although the 3 year total shareholder return declined 26.02%...

Investors in Engie SA ( EPA:ENGI ) had a good week, as its shares rose 2.7% to close at €26.87 following the release of...

The European stock market has recently experienced a positive momentum, with the STOXX Europe 600 Index reaching new highs driven by strong corporate earnings and renewed interest in AI-related stocks. Amidst this backdrop, identifying undervalued stocks becomes crucial as investors seek opportunities that are priced below their intrinsic value, offering potential for future growth within a recovering economy.

The European market has recently seen a positive uptick, with the STOXX Europe 600 Index reaching new highs driven by robust corporate earnings and renewed optimism in AI-related stocks. As investors navigate this landscape, identifying undervalued stocks can offer potential opportunities for those looking to capitalize on discrepancies between a company's intrinsic value and its current market price.

Soitec (ENXTPA:SOI) is back in focus after first quarter revenue reached €113 million, compared to €92 million a year earlier, alongside fresh guidance and capacity news in its Photonics-SOI business. See our latest analysis for Soitec. Soitec’s recent guidance around more than 30% expected year on year revenue growth in the second quarter and the ramp up of its Singapore Photonics SOI capacity has coincided with short term momentum. The 1 day share price return is 5.1% and the 7 day share...

ERAMET (ENXTPA:ERA) has drawn fresh investor attention after reporting mixed second quarter and first half 2026 production figures, confirming full year guidance and outlining progress on manganese projects in Gabon. See our latest analysis for ERAMET. ERAMET's recent production update and confirmed guidance come against a weak backdrop for the stock, with the share price down 26.29% over 90 days and the 1 year total shareholder return declining 9.11%. However, short term share price momentum...

Elis SA recently reported its half-year results for the period ended June 30, 2026, with sales of €2,457.1 million and net income of €163.6 million, both higher than a year earlier, and basic earnings per share from continuing operations rising to €0.73. The concurrent increase in sales, net income and both basic and diluted earnings per share highlights operational efficiency gains that build on Elis’s recurring-revenue model. We’ll now examine how this half-year improvement in sales and...

Schneider Electric (ENXTPA:SU) has drawn fresh attention after reporting half year 2026 sales of €21.226b and net income of €2.488b, alongside rising interest in its AI focused data center infrastructure. See our latest analysis for Schneider Electric. The latest results and AI focused announcements have arrived alongside firm price momentum for Schneider Electric, with the stock showing a 22.17% year to date share price return and a 37.51% one year total shareholder return. This suggests...

BNP Paribas (ENXTPA:BNP) is in focus after the Board approved an interim dividend of €3.23 per share, which is tied to first half 2026 net income and supported by stronger second quarter earnings. See our latest analysis for BNP Paribas. The interim dividend decision lands alongside a strong run in BNP Paribas’ share price, with a 30 day share price return of 8.40% and a 33.86% year to date share price return. Over longer horizons, total shareholder return of 52.58% over one year and 123.70%...

As European markets continue to show resilience with the STOXX Europe 600 Index reaching new highs, driven by strong corporate earnings and renewed interest in AI-related stocks, investors are increasingly looking toward dividend stocks as a stable source of income amidst economic growth surprises and inflationary pressures. In this environment, selecting robust dividend stocks can provide both steady income and potential capital appreciation, making them an attractive option for those...

SES (ENXTPA:SESG) has been in focus after the company reaffirmed its 2026 earnings guidance, indicating stable revenue for the year and outlining expectations for a stronger revenue profile in the second half. See our latest analysis for SES. Even with SES reaffirming its 2026 guidance and securing wins such as the LATAM Airlines inflight connectivity contract and progress on U.S. C-band incentives, the stock has seen the share price fall 27.06% over the past 30 days and 18.14% over 90 days,...

L'Air Liquide (ENXTPA:AI) is back in focus after a board meeting to review half year financials and a fresh earnings release, along with a planned gas facility investment of over US$150 million in Idaho. See our latest analysis for L'Air Liquide. The latest share price of €170.72 follows a 1-month share price return that declined 5.31% and a 7-day return that fell 3.29%. However, the year-to-date share price return is up 18.11% and the 5-year total shareholder return is 69.49%, suggesting...

Investors in Schneider Electric S.E. ( EPA:SU ) had a good week, as its shares rose 8.0% to close at €290 following the...

Teleperformance SE recently reported half-year 2026 results showing sales of €4,883 million and net income of €216 million, both below the prior year, alongside lower basic and diluted earnings per share from continuing operations. Alongside these softer figures, the company issued a cautious full-year 2026 outlook, targeting flat to low-single-digit like-for-like revenue growth, which may prompt investors to reassess its earnings resilience and efficiency efforts. Next, we will examine how...

Engie came into this earnings season with a stock that had slipped about 2.4% over the past week, yet still sat near €27, carrying a P/E below both its global utilities peers and the wider sector. The headline today is not the share price; it is Engie lifting full year net recurring income guidance to €4.9b to €5.5b after reporting roughly €3.0b for the first half and absorbing a heavy €19b outlay for U.K. Power Networks. Love Engie’s upgraded income guidance but cautious about the capital...

Crédit Agricole headed into this earnings season with the stock at €19.28 and solid short term gains, up about 4% over a week and 16% over three months. The share price already reflected rising optimism. The Q2 release then landed with a clear headline. Group revenues and net income reached record levels, while the trailing P/E sat at 9x, below both European banking peers and the wider French market. For long term investors, this mix of strong profitability and a discounted valuation raises a...

Investors pushed AXA to €44.94 at the 31 July close, capping a steady run over the past quarter. The stock looks calm on the screen while the earnings print tells a stronger story. Underlying earnings per share rose 8% in the first half and return on equity landed at 18%. That is a punchy outcome for a global insurer that still trades on a trailing P/E of 12.7x, below peers. The market focused on the day’s move. Long term investors will likely focus on that earnings power and the confirmation...

Forvia stock went into this earnings season trading at a steep discount, with a P/S ratio around 0.1x compared with higher industry levels and a 90 day share price decline of about 11%. The main takeaway from these results is not the income statement but the strain on the balance sheet and the reliance on future improvement to relieve it. Management reported net cash flow of €432m in the first half, progress on lowering net debt to €5.5b and a leverage ratio of 1.6x. That cash and...

Sanofi stock is down 9.5% year to date, yet the broader valuation checks still point to shares that screen on the cheap side rather than expensive. Recent headlines around strong product momentum on one side and pipeline setbacks on the other add extra focus to whether the current price fairly reflects the risk and reward mix. Sanofi has declined 9.5% year to date, which means investors are looking at a stock that has lagged while the underlying valuation signals suggest potential...